Our present and previous human postmortem brain studies [29–31] not only suggest that alterations in ERK1/2 may be important in the pathophysiology of depression but also raise the interesting possibility that ERK1/2 may be involved in generating vulnerability to depression phenotype. Here, MAPK3 is linked to depressive symptom measurement.